LOBEF (Lobe Sciences) Common Stock: $25.62 Mil (As of Feb. 2026)


What is Lobe Sciences Common Stock?

Lobe Sciences LOBEF +10.34% Common Stock is $25.62 Mil as of Feb. 2026. The stock has 2 warning signs investors should review.

Lobe Sciences's quarterly common stock declined from Aug. 2025 ($25.16 Mil) to Nov. 2025 ($24.87 Mil) but then increased from Nov. 2025 ($24.87 Mil) to Feb. 2026 ($25.62 Mil).

Lobe Sciences's annual common stock increased from Aug. 2023 ($20.50 Mil) to Aug. 2024 ($22.42 Mil) and increased from Aug. 2024 ($22.42 Mil) to Aug. 2025 ($25.16 Mil).

Lobe Sciences Common Stock Historical Data

* Premium members only.

The historical data trend for Lobe Sciences's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Lobe Sciences Common Stock Chart

Lobe Sciences Annual Data
Trend Dec16 Dec17 Dec18 Aug19 Aug20 Aug21 Aug22 Aug23 Aug24 Aug25
Common Stock
Get a 7-Day Free Trial Premium Member Only Premium Member Only 19.72 19.53 20.50 22.42 25.16

Lobe Sciences Quarterly Data
May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24 Nov24 Feb25 May25 Aug25 Nov25 Feb26
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 21.71 22.41 25.16 24.87 25.62

Lobe Sciences Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Frequently Asked Questions Learn more about Common Stock →
What does a Common Stock of $25.62 Mil mean?
Lobe Sciences (LOBEF) has a Common Stock of $25.62 Mil as of Feb. 2026. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Lobe Sciences and its competitors.
Is Lobe Sciences' Common Stock too high?
Lobe Sciences' current Common Stock is $25.62 Mil.
How does Lobe Sciences' Common Stock compare to VRTX and REGN?
Lobe Sciences' Common Stock of $25.62 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Common Stock for a Biotechnology company?
A good Common Stock depends on the Biotechnology industry context. However, Common Stock should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Common Stock mean?
A high Common Stock can signal that a stock is expensive relative to its fundamentals. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Lobe Sciences and its competitors. Lobe Sciences's current Common Stock is $25.62 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Lobe Sciences stock overvalued right now?
Lobe Sciences (LOBEF) has a current Common Stock of $25.62 Mil. The current Common Stock is $25.62 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Common Stock calculated?
Common Stock is calculated from a company's financial statements. For Lobe Sciences (LOBEF), the current Common Stock is $25.62 Mil as of Feb. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Lobe Sciences Business Description

Other Exchanges LOBE:GermanyLOBE:Canada
Address 1771 Robson Street, No. 1614, Vancouver, BC, CAN, V6G 3B7
Lobe Sciences Ltd is a biopharmaceutical company focused on using lipid technology that develop therapies for orphan and rare diseases. It commercializes Altemia MF, a medical food intended to address nutritional deficiencies associated with sickle cell disease. Through its subsidiaries, the company also holds a majority interest in the development of Conjugated Psilocin for potential use in neurological and psychiatric indications. The company operates in one reportable segment, being the biopharmaceutical development of new medicines.